Alx Oncology Holdings INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Lightstone Ventures and associated entities have filed an amendment to their Schedule 13D, reporting a decrease in their beneficial ownership percentage of ALX Oncology Holdings Inc. due to share dilution.
NASDAQ
venBio Global Strategic Fund II L.P. acquired over 3 million shares in ALX Oncology Holdings Inc.'s recent follow-on offering, increasing key investors' beneficial ownership to 10%.